TRIGGER
The Twice-Monthly Electronic Newsletter on the Biology of Tissue Factor, Factor VII and TFPI
Vol. 18, No. 1 January 3, 2012
__________________________________________________________
TRIGGER is also available by RSS Feed:
and BLOG:
http://trigger-tf7.blogspot.com/
__________________________________________________________
ANNOUNCEMENTS
As we have done for the past two years, the individual PubMed "collections" of the papers appearing in each issue of TRIGGER for 2011 have now been consolidated into a single collection. (The individual PubMed collections for each TRIGGER issue in 2011 have, accordingly, been deleted.) Here are the links to the consolidated collections for the past three years:
2009 (301 references):
http://www.ncbi.nlm.nih.gov/sites/myncbi/collections/public/1z_kd2hNzEEY8Wpxz8t1rph/
2010 (531references):
http://www.ncbi.nlm.nih.gov/sites/myncbi/collections/public/1-cH907gHdg5lzzYz_yPkW5/
2011 (612 references):
http://www.ncbi.nlm.nih.gov/sites/myncbi/collections/public/1bOQXIskFcJPXOjjcawlCfD/
__________________________________________________________
PAPERS IN PRESS
None submitted for this issue.
__________________________________________________________
RECENT PUBLICATIONS ON TISSUE FACTOR, FACTOR VII, AND TFPI
ABOUT TRIGGER
TRIGGER is edited by Jim Morrissey and Pierre Neuenschwander, with editorial assistance by Genie Morrissey. It includes Abstracts of Papers in Press, Meeting Announcements, Positions Sought/Available,or any other pertinent item that subscribers may want to share with their colleagues. To submit an item for publication in Trigger, e-mail us. To request or cancel a subscription,or for more information about TRIGGER or the biology of tissue factor and factor VII, visit our web site. You can also contact us by mail: J.H. Morrissey, University of Illinois College of Medicine, 417 Med Sci Bldg MC-714, 506 S. Mathews Ave., Urbana, IL 61801, USA.
DISCLAIMER: TRIGGER is provided "as is" for information purposes only and without warranty of any kind, express or implied. Users shall assume the entire risk as to the accuracy and usefulness of information in TRIGGER. Opinions expressed here are not necessarily those of the editors or their employers. You may share TRIGGER with your scientific colleagues but you are not permitted to use it or its contents for commercial purposes.
__________________________________________________________
The Twice-Monthly Electronic Newsletter on the Biology of Tissue Factor, Factor VII and TFPI
Vol. 18, No. 1 January 3, 2012
(The next issue will be on January 17, 2012)
TRIGGER is also available by RSS Feed:
and BLOG:
http://trigger-tf7.blogspot.com/
__________________________________________________________
ANNOUNCEMENTS
As we have done for the past two years, the individual PubMed "collections" of the papers appearing in each issue of TRIGGER for 2011 have now been consolidated into a single collection. (The individual PubMed collections for each TRIGGER issue in 2011 have, accordingly, been deleted.) Here are the links to the consolidated collections for the past three years:
2009 (301 references):
http://www.ncbi.nlm.nih.gov/sites/myncbi/collections/public/1z_kd2hNzEEY8Wpxz8t1rph/
2010 (531references):
http://www.ncbi.nlm.nih.gov/sites/myncbi/collections/public/1-cH907gHdg5lzzYz_yPkW5/
2011 (612 references):
http://www.ncbi.nlm.nih.gov/sites/myncbi/collections/public/1bOQXIskFcJPXOjjcawlCfD/
__________________________________________________________
PAPERS IN PRESS
None submitted for this issue.
__________________________________________________________
RECENT PUBLICATIONS ON TISSUE FACTOR, FACTOR VII, AND TFPI
Papers are culled from NLM MedLine (PubMed). Titles in square brackets indicate that the paper was not published in English. References that lack volume or page numbers are typically electronic pre-publications (E-pubs) ahead of the print publication; if so, the final citation with volume and page numbers may or may not appear in a future issue of Trigger.
THE FOLLOWING LINK WILL TAKE YOU TO THE ENTIRE LIST OF THIS ISSUE'S PUBLICATIONS IN A PUBMED "COLLECTION":
http://www.ncbi.nlm.nih.gov/sites/myncbi/collections/public/1dUWxDhhurzbOreoEFLTYft/
Basavaraj MG, Sovershaev MA, Egorina EM, Gruber FX, Bogdanov VY, Fallon JT, . . . Hansen JB (2011) Circulating monocytes mirror the imbalance in TF and TFPI expression in carotid atherosclerotic plaques with lipid-rich and calcified morphology. Thromb Res.
http://www.ncbi.nlm.nih.gov/pubmed/22178066
Bauer EM, Zheng H, Comhair S, Erzurum S, Billiar TR, Bauer PM (2011) Complement c3 deficiency attenuates chronic hypoxia-induced pulmonary hypertension in mice. PLoS One 6:e28578.
http://www.ncbi.nlm.nih.gov/pubmed/22194859
Bhat S, Yadav SP, Anjan M, Dinand V, Sachdeva A (2011) Recombinant activated factor VII usage in life threatening hemorrhage: a pediatric experience. Indian J Pediatr 78:961-968.
http://www.ncbi.nlm.nih.gov/pubmed/21328080
Branchini A, Rizzotto L, Mariani G, Napolitano M, Lapecorella M, Giansily-Blaizot M, . . . Bernardi F (2011) Natural and engineered carboxy-terminal variants: decreased secretion and gain-of-function result in asymptomatic coagulation factor VII deficiency. Haematologica.
http://www.ncbi.nlm.nih.gov/pubmed/22180436
Broze GJ, Jr., Girard TJ (2012) Tissue factor pathway inhibitor: structure-function. Front Biosci 17:262-280.
http://www.ncbi.nlm.nih.gov/pubmed/22201743
Butenas S, Amblo-Krudysz J, Mann KG (2012) Posttranslational modifications of tissue factor. Front Biosci (Elite Ed) 4:381-391.
http://www.ncbi.nlm.nih.gov/pubmed/22201880
Camera M, Brambilla M, Facchinetti L, Canzano P, Spirito R, Rossetti L, . . . Tremoli E (2011) Tissue Factor and Atherosclerosis: Not only vessel wall-derived TF, but also platelet-associated TF. Thromb Res.
http://www.ncbi.nlm.nih.gov/pubmed/22178579
Darlington DN, Delgado AV, Kheirabadi BS, Fedyk CG, Scherer MR, Pusateri AE, . . . Dubick MA (2011) Effect of hemodilution on coagulation and recombinant factor VIIa efficacy in human blood in vitro. J Trauma 71:1152-1163.
http://www.ncbi.nlm.nih.gov/pubmed/21610535
Delacroix S, Simari RD (2012) Tissue Factor-Thrombin-PAR-1 Pathway: A Novel Link Between Bone Marrow and Blood Vessel. Arterioscler Thromb Vasc Biol 32:3-4.
http://www.ncbi.nlm.nih.gov/pubmed/22173975
Dong X, Song L, Zhu D, Zhang H, Liu L, Leng X (2011) Tissue factor pathway inhibitor suppresses the growth of human vascular smooth muscle cells through regulating cell cycle. Mol Biol Rep 38:4771-4776.
http://www.ncbi.nlm.nih.gov/pubmed/21132373
Elmer J, Wittels KA (2011) Emergency reversal of pentasaccharide anticoagulants: a systematic review of the literature. Transfus Med.
http://www.ncbi.nlm.nih.gov/pubmed/22171588
Fukuda T, Honda Y, Kamisato C, Morishima Y, Shibano T (2011) Reversal of anticoagulant effects of edoxaban, an oral, direct factor Xa inhibitor, with haemostatic agents. Thromb Haemost 107.
http://www.ncbi.nlm.nih.gov/pubmed/22186946
Govindarajan S, Sivakumar J, Garimidi P, Rangaraj N, Kumar JM, Rao NM, Gopal V (2011) Targeting human epidermal growth factor receptor 2 by a cell-penetrating peptide-affibody bioconjugate. Biomaterials.
http://www.ncbi.nlm.nih.gov/pubmed/22192536
Hampton AL, Diaz JA, Hawley AE, Wrobleski SK, Wang JG, Lee RD, . . . Myers DD, Jr. (2011) Myeloid cell tissue factor does not contribute to venous thrombogenesis in an electrolytic injury model. Thromb Res.
http://www.ncbi.nlm.nih.gov/pubmed/22192154
Harkouk H, Chakib Rahmoune F, Benhamou D (2011) [Postpartum haemorrhage and factor VII deficiency.]. Ann Fr Anesth Reanim.
http://www.ncbi.nlm.nih.gov/pubmed/22197042
Haynes LM, Dubief YC, Mann KG (2011) Membrane binding events in the initiation and propagation phases of tissue factor initiated zymogen activation under flow. J Biol Chem.
http://www.ncbi.nlm.nih.gov/pubmed/22187432
Hedner U (2012) FVIIa as therapeutic agent in hemophilia and beyond. Front Biosci (Elite Ed) 4:1210-1223.
http://www.ncbi.nlm.nih.gov/pubmed/22201947
Hoffman M, Monroe DM (2012) The multiple roles of tissue factor in wound healing. Front Biosci (Schol Ed) 4:713 -721.
http://www.ncbi.nlm.nih.gov/pubmed/22202116
Holroyd EW, White TA, Pan S, Simari RD (2012) Tissue factor pathway inhibitor as a multifunctional mediator of vascular structure. Front Biosci (Elite Ed) 4:392-400.
http://www.ncbi.nlm.nih.gov/pubmed/22201881
Jansen JO, Scarpelini S, Pinto R, Tien HC, Callum J, Rizoli SB (2011) Hypoperfusion in severely injured trauma patients is associated with reduced coagulation factor activity. J Trauma 71:S435-440.
http://www.ncbi.nlm.nih.gov/pubmed/22072000
Kuperman AA, Kenet G, Papadakis E, Brenner B (2011) Intraventricular hemorrhage in preterm infants: coagulation perspectives. Semin Thromb Hemost 37:730-736.
http://www.ncbi.nlm.nih.gov/pubmed/22187395
Lester PA, Diaz JA, Shuster KA, Henke PK, Wakefield TW, Myers DD (2012) Inflammation and thrombosis: new insights. Front Biosci (ScholEd) 4:620-638.
http://www.ncbi.nlm.nih.gov/pubmed/22202081
Li S, Zhang S, Li N, Li Z, Yu B, Tian Y (2011) Arterial Smooth Muscle Injury causes Blood Tissue Factor Elevation Predicting Restenosis after PCI. Scand Cardiovasc J.
http://www.ncbi.nlm.nih.gov/pubmed/22204555
Liak C, Fitzpatrick M (2011) Coagulability in obstructive sleep apnea. Can Respir J 18:338-348.
http://www.ncbi.nlm.nih.gov/pubmed/22187690
Lippi G, Franchini M, Targher G (2011) Arterial thrombus formation in cardiovascular disease. Nat Rev Cardiol 8:502-512.
http://www.ncbi.nlm.nih.gov/pubmed/21727917
Lupu C, Zhu H, Popescu NI, Wren JD, Lupu F (2011) Novel protein ADTRP regulates TFPI expression and function in human endothelial cells in normal conditions and in response to androgen. Blood 118:4463-4471.
http://www.ncbi.nlm.nih.gov/pubmed/21868574
Mahmoodi M, Peyvandi F, Afrasiabi A, Ghaffarpasand F, Karimi M (2011) Bleeding symptoms in heterozygous carriers of inherited coagulation disorders in southern Iran. Blood Coagul Fibrinolysis 22:396-401.
http://www.ncbi.nlm.nih.gov/pubmed/21451397
Margaritis P (2012) Gene-based continuous expression of FVIIa for the treatment of hemophilia. Front Biosci (Schol Ed) 4:287-299.
http://www.ncbi.nlm.nih.gov/pubmed/22202061
Mirzaahmadi S, Asaadi-Tehrani G, Bandehpour M, Davoudi N, Tahmasbi L, Hosseinzadeh N, . . . Kazemi B (2011) Expression of recombinant human coagulation factor VII by the Lizard Leishmania expression system. J Biomed Biotechnol 2011:873874.
http://www.ncbi.nlm.nih.gov/pubmed/21912483
Motoki Y, Nojima J, Yanagihara M, Tsuneoka H, Matsui T, Yamamoto M, Ichihara K (2011) Anti-phospholipid antibodies contribute to arteriosclerosis in patients with systemic lupus erythematosus through induction of tissue factor expression and cytokine production from peripheral blood mononuclear cells. Thromb Res.
http://www.ncbi.nlm.nih.gov/pubmed/22196362
Muzaffar J, Katragadda L, Haider S, Javed A, Anaissie E, Usmani S (2011) Rituximab and intravenous immunoglobulin (IVIG) for the management of acquired factor VIII inhibitor in multiple myeloma: case report and review of literature. Int J Hematol.
http://www.ncbi.nlm.nih.gov/pubmed/22170228
Nagle EL, Tsu LV, Dager WE (2011) Bivalirudin for anticoagulation during hypothermic cardiopulmonary bypass and recombinant factor VIIa for iatrogenic coagulopathy. Ann Pharmacother 45:e47.
http://www.ncbi.nlm.nih.gov/pubmed/21862711
Napoleone E, Cutrone A, Cugino D, Amore C, Di Santo A, Iacoviello L, . . . Lorenzet R (2011) Inhibition of the renin-angiotensin system downregulates tissue factor and vascular endothelial growth factor in human breast carcinoma cells. Thromb Res.
http://www.ncbi.nlm.nih.gov/pubmed/22188725
Notarnicola A, Pesce V, Scaraggi A, Maccagnano G, Vicenti G, Moretti B (2011) Total hip replacement in a patient with acquired haemophilia A: a case report and literature review. Blood Coagul Fibrinolysis 22:436-439.
http://www.ncbi.nlm.nih.gov/pubmed/21508830
Oslakovic C, Cedervall T, Linse S, Dahlback B (2011) Polystyrene nanoparticles affecting blood coagulation. Nanomedicine.
http://www.ncbi.nlm.nih.gov/pubmed/22197724
Osterud B (2011) Tissue factor/TFPI and blood cells. Thromb Res.
http://www.ncbi.nlm.nih.gov/pubmed/22197177
Osterud B, Bjorklid E (2012) Tissue factor in blood cells and endothelial cells. Front Biosci (Elite Ed) 4:289-299.
http://www.ncbi.nlm.nih.gov/pubmed/22201871
Potaczek DP, Pieculewicz M, Mazur M, Branicka A, Nishiyama C, Okumura K, Undas A (2011) Very rare minor homozygous GG genotype of tissue factor +5466A>G mutation in a patient with two cryptogenic cerebrovascular ischemic events. Int J Cardiol 147:e13-15.
http://www.ncbi.nlm.nih.gov/pubmed/19203804
Rao LV, Kothari H, Pendurthi UR (2012) Tissue factor: mechanisms of decryption. Front Biosci (Elite Ed) 4:1513-1527.
http://www.ncbi.nlm.nih.gov/pubmed/22201972
Rolfe S, Papadopoulos S, Cabral KP (2010) Controversies of anticoagulation reversal in life-threatening bleeds. J Pharm Pract 23:217-225.
http://www.ncbi.nlm.nih.gov/pubmed/21507817
Sarode R, Matevosyan K, Bhagat R, Rutherford C, Madden C, Beshay JE (2011) Rapid warfarin reversal: a 3-factor prothrombin complex concentrate and recombinant factor VIIa cocktail for intracerebral hemorrhage. J Neurosurg.
http://www.ncbi.nlm.nih.gov/pubmed/22175718
Shapiro A, Cooper DL (2011) U.S. survey of surgical capabilities and experience with surgical procedures in patients with congenital haemophilia with inhibitors. Haemophilia.
http://www.ncbi.nlm.nih.gov/pubmed/22168829
Solheim S, Seljeflot I, Lunde K, Bratseth V, Aakhus S, Forfang K, Arnesen H (2011) The influence of intracoronary injection of bone marrow cells on prothrombotic markers in patients with acute myocardial infarction. Thromb Res.
http://www.ncbi.nlm.nih.gov/pubmed/22192151
Undas A, Machnik A, Potaczek DP, Wypasek E, Zmudka K, Tracz W (2011) Ezetimibe combined with simvastatin compared with simvastatin alone results in a greater suppression of oxidative stress and enhanced fibrinolysis in patients after acute coronary events. J Cardiovasc Pharmacol 58:167-172.
http://www.ncbi.nlm.nih.gov/pubmed/21558878
Uszynski M, Zekanowska E, Uszynski W, Kuczynski J, Zylinski A (2011) Microparticles (MPs), tissue factor (TF) and tissue factor inhibitor (TFPI) in cord blood plasma. A preliminary study and literature survey of procoagulant properties of MPs. Eur J Obstet Gynecol Reprod Biol 158:37-41.
http://www.ncbi.nlm.nih.gov/pubmed/21664032
Wang CH, Chen YC, Tsao CW, Yang SS (2011) Dalteparin-associated catastrophic retroperitoneal hematoma successfully treated with recombinant factor VIIa. Int Urol Nephrol.
http://www.ncbi.nlm.nih.gov/pubmed/22180040
Williams JC, Mackman N (2012) Tissue factor in health and disease. Front Biosci (Elite Ed) 4:358-372.
http://www.ncbi.nlm.nih.gov/pubmed/22201878
Witting PK, Song C, Hsu K, Hua S, Parry SN, Aran R, . . . Freedman SB (2011) The acute-phase protein serum amyloid A induces endothelial dysfunction that is inhibited by high-density lipoprotein. Free Radic Biol Med 51:1390-1398.
http://www.ncbi.nlm.nih.gov/pubmed/21784147
Wolthuis EK, Vlaar AP, Choi G, Roelofs JJ, Levi M, Juffermans NP, Schultz MJ (2012) Relative Tissue Factor Deficiency Attenuates Ventilator-Induced Coagulopathy but Does Not Protect against Ventilator-Induced Lung Injury in Mice. Crit Care Res Pract 2012:130410.
http://www.ncbi.nlm.nih.gov/pubmed/22195278
Young G, Shapiro AD, Walsh CE, Gruppo RA, Gut RZ, Cooper DL (2011) Patient/Caregiver-reported recombinant factor VIIa (rFVIIa) dosing: home treatment of acute bleeds in the Dosing Observational Study in Hemophilia (DOSE). Haemophilia.
http://www.ncbi.nlm.nih.gov/pubmed/22171621
Zhang Q, Zhang Y, Wang SZ, Wang N, Jiang WG, Ji YH, Zhang SL (2012) Reduced expression of Tissue factor pathway inhibitor-2 contributes to apoptosis and angiogenesis in cervical cancer. J Exp Clin Cancer Res 31:1.
http://www.ncbi.nlm.nih.gov/pubmed/22208663
Zhou Q, Xiong Y, Cheng Y, Du Y, Zhang J, Mu J, . . . Li X (2011) Effects of Tissue Factor Pathway Inhibitor-2 Expression on Biological Behavior of BeWo and JEG-3 Cell Lines. Clin Appl Thromb Hemost.
http://www.ncbi.nlm.nih.gov/pubmed/22203034
__________________________________________________________
http://www.ncbi.nlm.nih.gov/sites/myncbi/collections/public/1dUWxDhhurzbOreoEFLTYft/
Basavaraj MG, Sovershaev MA, Egorina EM, Gruber FX, Bogdanov VY, Fallon JT, . . . Hansen JB (2011) Circulating monocytes mirror the imbalance in TF and TFPI expression in carotid atherosclerotic plaques with lipid-rich and calcified morphology. Thromb Res.
http://www.ncbi.nlm.nih.gov/pubmed/22178066
Bauer EM, Zheng H, Comhair S, Erzurum S, Billiar TR, Bauer PM (2011) Complement c3 deficiency attenuates chronic hypoxia-induced pulmonary hypertension in mice. PLoS One 6:e28578.
http://www.ncbi.nlm.nih.gov/pubmed/22194859
Bhat S, Yadav SP, Anjan M, Dinand V, Sachdeva A (2011) Recombinant activated factor VII usage in life threatening hemorrhage: a pediatric experience. Indian J Pediatr 78:961-968.
http://www.ncbi.nlm.nih.gov/pubmed/21328080
Branchini A, Rizzotto L, Mariani G, Napolitano M, Lapecorella M, Giansily-Blaizot M, . . . Bernardi F (2011) Natural and engineered carboxy-terminal variants: decreased secretion and gain-of-function result in asymptomatic coagulation factor VII deficiency. Haematologica.
http://www.ncbi.nlm.nih.gov/pubmed/22180436
Broze GJ, Jr., Girard TJ (2012) Tissue factor pathway inhibitor: structure-function. Front Biosci 17:262-280.
http://www.ncbi.nlm.nih.gov/pubmed/22201743
Butenas S, Amblo-Krudysz J, Mann KG (2012) Posttranslational modifications of tissue factor. Front Biosci (Elite Ed) 4:381-391.
http://www.ncbi.nlm.nih.gov/pubmed/22201880
Camera M, Brambilla M, Facchinetti L, Canzano P, Spirito R, Rossetti L, . . . Tremoli E (2011) Tissue Factor and Atherosclerosis: Not only vessel wall-derived TF, but also platelet-associated TF. Thromb Res.
http://www.ncbi.nlm.nih.gov/pubmed/22178579
Darlington DN, Delgado AV, Kheirabadi BS, Fedyk CG, Scherer MR, Pusateri AE, . . . Dubick MA (2011) Effect of hemodilution on coagulation and recombinant factor VIIa efficacy in human blood in vitro. J Trauma 71:1152-1163.
http://www.ncbi.nlm.nih.gov/pubmed/21610535
Delacroix S, Simari RD (2012) Tissue Factor-Thrombin-PAR-1 Pathway: A Novel Link Between Bone Marrow and Blood Vessel. Arterioscler Thromb Vasc Biol 32:3-4.
http://www.ncbi.nlm.nih.gov/pubmed/22173975
Dong X, Song L, Zhu D, Zhang H, Liu L, Leng X (2011) Tissue factor pathway inhibitor suppresses the growth of human vascular smooth muscle cells through regulating cell cycle. Mol Biol Rep 38:4771-4776.
http://www.ncbi.nlm.nih.gov/pubmed/21132373
Elmer J, Wittels KA (2011) Emergency reversal of pentasaccharide anticoagulants: a systematic review of the literature. Transfus Med.
http://www.ncbi.nlm.nih.gov/pubmed/22171588
Fukuda T, Honda Y, Kamisato C, Morishima Y, Shibano T (2011) Reversal of anticoagulant effects of edoxaban, an oral, direct factor Xa inhibitor, with haemostatic agents. Thromb Haemost 107.
http://www.ncbi.nlm.nih.gov/pubmed/22186946
Govindarajan S, Sivakumar J, Garimidi P, Rangaraj N, Kumar JM, Rao NM, Gopal V (2011) Targeting human epidermal growth factor receptor 2 by a cell-penetrating peptide-affibody bioconjugate. Biomaterials.
http://www.ncbi.nlm.nih.gov/pubmed/22192536
Hampton AL, Diaz JA, Hawley AE, Wrobleski SK, Wang JG, Lee RD, . . . Myers DD, Jr. (2011) Myeloid cell tissue factor does not contribute to venous thrombogenesis in an electrolytic injury model. Thromb Res.
http://www.ncbi.nlm.nih.gov/pubmed/22192154
Harkouk H, Chakib Rahmoune F, Benhamou D (2011) [Postpartum haemorrhage and factor VII deficiency.]. Ann Fr Anesth Reanim.
http://www.ncbi.nlm.nih.gov/pubmed/22197042
Haynes LM, Dubief YC, Mann KG (2011) Membrane binding events in the initiation and propagation phases of tissue factor initiated zymogen activation under flow. J Biol Chem.
http://www.ncbi.nlm.nih.gov/pubmed/22187432
Hedner U (2012) FVIIa as therapeutic agent in hemophilia and beyond. Front Biosci (Elite Ed) 4:1210-1223.
http://www.ncbi.nlm.nih.gov/pubmed/22201947
Hoffman M, Monroe DM (2012) The multiple roles of tissue factor in wound healing. Front Biosci (Schol Ed) 4:713 -721.
http://www.ncbi.nlm.nih.gov/pubmed/22202116
Holroyd EW, White TA, Pan S, Simari RD (2012) Tissue factor pathway inhibitor as a multifunctional mediator of vascular structure. Front Biosci (Elite Ed) 4:392-400.
http://www.ncbi.nlm.nih.gov/pubmed/22201881
Jansen JO, Scarpelini S, Pinto R, Tien HC, Callum J, Rizoli SB (2011) Hypoperfusion in severely injured trauma patients is associated with reduced coagulation factor activity. J Trauma 71:S435-440.
http://www.ncbi.nlm.nih.gov/pubmed/22072000
Kuperman AA, Kenet G, Papadakis E, Brenner B (2011) Intraventricular hemorrhage in preterm infants: coagulation perspectives. Semin Thromb Hemost 37:730-736.
http://www.ncbi.nlm.nih.gov/pubmed/22187395
Lester PA, Diaz JA, Shuster KA, Henke PK, Wakefield TW, Myers DD (2012) Inflammation and thrombosis: new insights. Front Biosci (ScholEd) 4:620-638.
http://www.ncbi.nlm.nih.gov/pubmed/22202081
Li S, Zhang S, Li N, Li Z, Yu B, Tian Y (2011) Arterial Smooth Muscle Injury causes Blood Tissue Factor Elevation Predicting Restenosis after PCI. Scand Cardiovasc J.
http://www.ncbi.nlm.nih.gov/pubmed/22204555
Liak C, Fitzpatrick M (2011) Coagulability in obstructive sleep apnea. Can Respir J 18:338-348.
http://www.ncbi.nlm.nih.gov/pubmed/22187690
Lippi G, Franchini M, Targher G (2011) Arterial thrombus formation in cardiovascular disease. Nat Rev Cardiol 8:502-512.
http://www.ncbi.nlm.nih.gov/pubmed/21727917
Lupu C, Zhu H, Popescu NI, Wren JD, Lupu F (2011) Novel protein ADTRP regulates TFPI expression and function in human endothelial cells in normal conditions and in response to androgen. Blood 118:4463-4471.
http://www.ncbi.nlm.nih.gov/pubmed/21868574
Mahmoodi M, Peyvandi F, Afrasiabi A, Ghaffarpasand F, Karimi M (2011) Bleeding symptoms in heterozygous carriers of inherited coagulation disorders in southern Iran. Blood Coagul Fibrinolysis 22:396-401.
http://www.ncbi.nlm.nih.gov/pubmed/21451397
Margaritis P (2012) Gene-based continuous expression of FVIIa for the treatment of hemophilia. Front Biosci (Schol Ed) 4:287-299.
http://www.ncbi.nlm.nih.gov/pubmed/22202061
Mirzaahmadi S, Asaadi-Tehrani G, Bandehpour M, Davoudi N, Tahmasbi L, Hosseinzadeh N, . . . Kazemi B (2011) Expression of recombinant human coagulation factor VII by the Lizard Leishmania expression system. J Biomed Biotechnol 2011:873874.
http://www.ncbi.nlm.nih.gov/pubmed/21912483
Motoki Y, Nojima J, Yanagihara M, Tsuneoka H, Matsui T, Yamamoto M, Ichihara K (2011) Anti-phospholipid antibodies contribute to arteriosclerosis in patients with systemic lupus erythematosus through induction of tissue factor expression and cytokine production from peripheral blood mononuclear cells. Thromb Res.
http://www.ncbi.nlm.nih.gov/pubmed/22196362
Muzaffar J, Katragadda L, Haider S, Javed A, Anaissie E, Usmani S (2011) Rituximab and intravenous immunoglobulin (IVIG) for the management of acquired factor VIII inhibitor in multiple myeloma: case report and review of literature. Int J Hematol.
http://www.ncbi.nlm.nih.gov/pubmed/22170228
Nagle EL, Tsu LV, Dager WE (2011) Bivalirudin for anticoagulation during hypothermic cardiopulmonary bypass and recombinant factor VIIa for iatrogenic coagulopathy. Ann Pharmacother 45:e47.
http://www.ncbi.nlm.nih.gov/pubmed/21862711
Napoleone E, Cutrone A, Cugino D, Amore C, Di Santo A, Iacoviello L, . . . Lorenzet R (2011) Inhibition of the renin-angiotensin system downregulates tissue factor and vascular endothelial growth factor in human breast carcinoma cells. Thromb Res.
http://www.ncbi.nlm.nih.gov/pubmed/22188725
Notarnicola A, Pesce V, Scaraggi A, Maccagnano G, Vicenti G, Moretti B (2011) Total hip replacement in a patient with acquired haemophilia A: a case report and literature review. Blood Coagul Fibrinolysis 22:436-439.
http://www.ncbi.nlm.nih.gov/pubmed/21508830
Oslakovic C, Cedervall T, Linse S, Dahlback B (2011) Polystyrene nanoparticles affecting blood coagulation. Nanomedicine.
http://www.ncbi.nlm.nih.gov/pubmed/22197724
Osterud B (2011) Tissue factor/TFPI and blood cells. Thromb Res.
http://www.ncbi.nlm.nih.gov/pubmed/22197177
Osterud B, Bjorklid E (2012) Tissue factor in blood cells and endothelial cells. Front Biosci (Elite Ed) 4:289-299.
http://www.ncbi.nlm.nih.gov/pubmed/22201871
Potaczek DP, Pieculewicz M, Mazur M, Branicka A, Nishiyama C, Okumura K, Undas A (2011) Very rare minor homozygous GG genotype of tissue factor +5466A>G mutation in a patient with two cryptogenic cerebrovascular ischemic events. Int J Cardiol 147:e13-15.
http://www.ncbi.nlm.nih.gov/pubmed/19203804
Rao LV, Kothari H, Pendurthi UR (2012) Tissue factor: mechanisms of decryption. Front Biosci (Elite Ed) 4:1513-1527.
http://www.ncbi.nlm.nih.gov/pubmed/22201972
Rolfe S, Papadopoulos S, Cabral KP (2010) Controversies of anticoagulation reversal in life-threatening bleeds. J Pharm Pract 23:217-225.
http://www.ncbi.nlm.nih.gov/pubmed/21507817
Sarode R, Matevosyan K, Bhagat R, Rutherford C, Madden C, Beshay JE (2011) Rapid warfarin reversal: a 3-factor prothrombin complex concentrate and recombinant factor VIIa cocktail for intracerebral hemorrhage. J Neurosurg.
http://www.ncbi.nlm.nih.gov/pubmed/22175718
Shapiro A, Cooper DL (2011) U.S. survey of surgical capabilities and experience with surgical procedures in patients with congenital haemophilia with inhibitors. Haemophilia.
http://www.ncbi.nlm.nih.gov/pubmed/22168829
Solheim S, Seljeflot I, Lunde K, Bratseth V, Aakhus S, Forfang K, Arnesen H (2011) The influence of intracoronary injection of bone marrow cells on prothrombotic markers in patients with acute myocardial infarction. Thromb Res.
http://www.ncbi.nlm.nih.gov/pubmed/22192151
Undas A, Machnik A, Potaczek DP, Wypasek E, Zmudka K, Tracz W (2011) Ezetimibe combined with simvastatin compared with simvastatin alone results in a greater suppression of oxidative stress and enhanced fibrinolysis in patients after acute coronary events. J Cardiovasc Pharmacol 58:167-172.
http://www.ncbi.nlm.nih.gov/pubmed/21558878
Uszynski M, Zekanowska E, Uszynski W, Kuczynski J, Zylinski A (2011) Microparticles (MPs), tissue factor (TF) and tissue factor inhibitor (TFPI) in cord blood plasma. A preliminary study and literature survey of procoagulant properties of MPs. Eur J Obstet Gynecol Reprod Biol 158:37-41.
http://www.ncbi.nlm.nih.gov/pubmed/21664032
Wang CH, Chen YC, Tsao CW, Yang SS (2011) Dalteparin-associated catastrophic retroperitoneal hematoma successfully treated with recombinant factor VIIa. Int Urol Nephrol.
http://www.ncbi.nlm.nih.gov/pubmed/22180040
Williams JC, Mackman N (2012) Tissue factor in health and disease. Front Biosci (Elite Ed) 4:358-372.
http://www.ncbi.nlm.nih.gov/pubmed/22201878
Witting PK, Song C, Hsu K, Hua S, Parry SN, Aran R, . . . Freedman SB (2011) The acute-phase protein serum amyloid A induces endothelial dysfunction that is inhibited by high-density lipoprotein. Free Radic Biol Med 51:1390-1398.
http://www.ncbi.nlm.nih.gov/pubmed/21784147
Wolthuis EK, Vlaar AP, Choi G, Roelofs JJ, Levi M, Juffermans NP, Schultz MJ (2012) Relative Tissue Factor Deficiency Attenuates Ventilator-Induced Coagulopathy but Does Not Protect against Ventilator-Induced Lung Injury in Mice. Crit Care Res Pract 2012:130410.
http://www.ncbi.nlm.nih.gov/pubmed/22195278
Young G, Shapiro AD, Walsh CE, Gruppo RA, Gut RZ, Cooper DL (2011) Patient/Caregiver-reported recombinant factor VIIa (rFVIIa) dosing: home treatment of acute bleeds in the Dosing Observational Study in Hemophilia (DOSE). Haemophilia.
http://www.ncbi.nlm.nih.gov/pubmed/22171621
Zhang Q, Zhang Y, Wang SZ, Wang N, Jiang WG, Ji YH, Zhang SL (2012) Reduced expression of Tissue factor pathway inhibitor-2 contributes to apoptosis and angiogenesis in cervical cancer. J Exp Clin Cancer Res 31:1.
http://www.ncbi.nlm.nih.gov/pubmed/22208663
Zhou Q, Xiong Y, Cheng Y, Du Y, Zhang J, Mu J, . . . Li X (2011) Effects of Tissue Factor Pathway Inhibitor-2 Expression on Biological Behavior of BeWo and JEG-3 Cell Lines. Clin Appl Thromb Hemost.
http://www.ncbi.nlm.nih.gov/pubmed/22203034
__________________________________________________________
TRIGGER is edited by Jim Morrissey and Pierre Neuenschwander, with editorial assistance by Genie Morrissey. It includes Abstracts of Papers in Press, Meeting Announcements, Positions Sought/Available,or any other pertinent item that subscribers may want to share with their colleagues. To submit an item for publication in Trigger, e-mail us. To request or cancel a subscription,or for more information about TRIGGER or the biology of tissue factor and factor VII, visit our web site. You can also contact us by mail: J.H. Morrissey, University of Illinois College of Medicine, 417 Med Sci Bldg MC-714, 506 S. Mathews Ave., Urbana, IL 61801, USA.
DISCLAIMER: TRIGGER is provided "as is" for information purposes only and without warranty of any kind, express or implied. Users shall assume the entire risk as to the accuracy and usefulness of information in TRIGGER. Opinions expressed here are not necessarily those of the editors or their employers. You may share TRIGGER with your scientific colleagues but you are not permitted to use it or its contents for commercial purposes.
__________________________________________________________
